225 related articles for article (PubMed ID: 10884941)
21. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
22. [Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases].
Jirásková M; Jirásek L; Stork J; Vosmík F; Jirsa M
Cas Lek Cesk; 2003 Aug; 142(8):493-9. PubMed ID: 14626566
[TBL] [Abstract][Full Text] [Related]
23. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
[TBL] [Abstract][Full Text] [Related]
24. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
Baptista J; Martinez C; Leite L; Cochito M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
[TBL] [Abstract][Full Text] [Related]
25. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
26. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery.
Nordin P; Larkö O; Stenquist B
Br J Dermatol; 1997 Feb; 136(2):180-3. PubMed ID: 9068728
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid.
Calzavara-Pinton PG; Venturini M; Capezzera R; Sala R; Zane C
Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):144-7. PubMed ID: 15144392
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative photodynamic therapy: a description of a new adjuvant technique for patients with nonmelanoma skin cancer.
Marmur ES; Nolan KA; Henry M
Dermatol Surg; 2012 Jul; 38(7 Pt 1):1073-6. PubMed ID: 22607107
[No Abstract] [Full Text] [Related]
30. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.
Oseroff AR; Shieh S; Frawley NP; Cheney R; Blumenson LE; Pivnick EK; Bellnier DA
Arch Dermatol; 2005 Jan; 141(1):60-7. PubMed ID: 15655143
[TBL] [Abstract][Full Text] [Related]
31. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
Lee DA; Ratner D
Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
[TBL] [Abstract][Full Text] [Related]
32. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure.
Morris DS; Elzaridi E; Clarke L; Dickinson AJ; Lawrence CM
Br J Ophthalmol; 2009 Apr; 93(4):474-6. PubMed ID: 19060015
[TBL] [Abstract][Full Text] [Related]
33. Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery.
Redondo P; Marquina M; Pretel M; Aguado L; Iglesias ME
Arch Dermatol; 2008 Jan; 144(1):115-7. PubMed ID: 18209183
[No Abstract] [Full Text] [Related]
34. Choice of optimal wavelength for PDT: the significance of oxygen depletion.
Nielsen KP; Juzeniene A; Juzenas P; Stamnes K; Stamnes JJ; Moan J
Photochem Photobiol; 2005; 81(5):1190-4. PubMed ID: 15934793
[TBL] [Abstract][Full Text] [Related]
35. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
[TBL] [Abstract][Full Text] [Related]
37. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence diagnostics of basal cell carcinomas comparing methyl-aminolaevulinate and aminolaevulinic acid and correlation with visual clinical tumour size.
Sandberg C; Paoli J; Gillstedt M; Halldin CB; Larkö O; Wennberg AM; Ericson MB
Acta Derm Venereol; 2011 Jun; 91(4):398-403. PubMed ID: 21597674
[TBL] [Abstract][Full Text] [Related]
39. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?
Moseley H; Brancaleon L; Lesar AE; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):72-5. PubMed ID: 18353086
[TBL] [Abstract][Full Text] [Related]
40. Treatment of basal cell carcinomas by general practitioners in Australia.
Streeton CL; Gospodarevskaya E; Harris A
Int J Dermatol; 2006 Apr; 45(4):345-51. PubMed ID: 16650155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
